Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$105.76 - $154.96 $528,800 - $774,800
-5,000 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$78.5 - $126.48 $219,800 - $354,144
-2,800 Reduced 35.9%
5,000 $527,000
Q4 2020

Feb 16, 2021

BUY
$55.93 - $82.78 $436,254 - $645,684
7,800 New
7,800 $618,000
Q3 2020

Nov 04, 2020

SELL
$45.65 - $61.81 $223,685 - $302,869
-4,900 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$29.15 - $61.54 $142,835 - $301,546
4,900 New
4,900 $301,000
Q1 2019

May 13, 2019

SELL
$27.81 - $40.78 $581,229 - $852,302
-20,900 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$28.91 - $50.0 $604,219 - $1.05 Million
20,900 New
20,900 $667,000

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.35B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.